Cadila Healthcare Limited Meloxicam Export Data — India (DGFT 2022–2026)

Name: Cadila Healthcare Limited Meloxicam Export Records India — #9 Exporter, 30 Shipments, $1.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Meloxicam

India Pharmaceutical Trade Intelligence

$199.4M277 Suppliers100 CountriesHS 30049066

ExportsIndia → UNITED STATES86.3%India → SERBIA3.0%

ImportsUNITED STATES → India$1.1M GERMANY → India$19.9K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Cadila Healthcare Limited — Meloxicam Exporter #9 | $1.5M Trade Value | TransData Nexus | TransData Nexus

Cadila Healthcare Limited — Meloxicam Exporter Profile

Indian Pharmaceutical Exporter · #9 for Meloxicam · $1.5M export value · DGFT Verified

Cadila Healthcare Limited is the #9 Indian exporter of Meloxicam with $1.5M in export value and 30 verified shipments. Cadila Healthcare Limited holds a 0.5% market share in Meloxicam exports across 3 countries. The company exports 41 pharmaceutical products worth $34.9M across 17 therapeutic categories.

Cadila Healthcare Limited — Meloxicam Export Profile: Buyers & Destinations

Cadila Healthcare Limited Meloxicam export treemap — buyers and destination countries | TransData Nexus

Where Does Cadila Healthcare Limited Export Meloxicam?

Country	Value	Shipments	Share
UNITED STATES	$1.1M	27	90.0%
THAILAND	$98.6K	6	8.0%
SOUTH AFRICA	$24.2K	6	2.0%

Cadila Healthcare Limited exports Meloxicam to 3 countries. The largest destination is UNITED STATES accounting for 90.0% of Cadila Healthcare Limited's Meloxicam shipments, followed by THAILAND (8.0%) and SOUTH AFRICA (2.0%). These destinations reflect Cadila Healthcare Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Meloxicam from Cadila Healthcare Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$979.9K	24
PRIORITY HEALTHCARE DISTRIBUTION DBA	UNITED STATES	$126.0K	3
PHARMALAND 1982 CO LIMITED	THAILAND	$98.6K	6
ZYDUS HEALTHCARE SA PTY LIMITED	SOUTH AFRICA	$24.2K	6

Cadila Healthcare Limited supplies Meloxicam to 4 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by PRIORITY HEALTHCARE DISTRIBUTION DBA (UNITED STATES) and PHARMALAND 1982 CO LIMITED (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Meloxicam Formulations Does Cadila Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA MEDICINE FOR HUMAN USE-MELOXICAM	$291.1K	8
MEL-OD 7.5MG MELOXICAM 7.5MG TABLETS 1	$55.9K	3
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1x500-QTY-15,360.000 PAC-AS PER INV	$50.0K	1
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 7.5 MG 1x500 -QTY-30,828.000 PAC-AS PER INV	$50.0K	1
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1x500-QTY-23,064.000 PAC-AS PER INV	$50.0K	1
MELOXICAM TABLETS USP 15 MG-1X500 NDC- 82009-130-05, B/N. Z303676,Z303825, MANUFACTURING .DT. 07/2023 EXP.DT. 06/2025	$50.0K	1
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1x500-QTY-31,080.000 PAC-AS PER INV	$50.0K	1
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1x500-QTY-15,444.000 PAC-AS PER INV	$50.0K	1
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 15 MG 1x100-QTY-76272.000 PAC-AS PER INV	$50.0K	1
PHARMA MEDICINE FOR HUMAN USE-MELOXICAMTABS USP 7.5 MG 1x500-QTY-30888.000 PAC-AS PER INV	$50.0K	1

Cadila Healthcare Limited exports 28 distinct Meloxicam formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA MEDICINE FOR HUMAN USE-MELOXICAM with 8 shipments worth $291.1K.

How Does Cadila Healthcare Limited Compare to Nearest Meloxicam Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	AUROBINDO PHARMA LTD	$1.1M	127	13	$8.4K
8	GRACURE PHARMACEUTICALS LIMITED	$1.0M	40	1	$26.0K
9	CADILA HEALTHCARE LIMITED ★	$1.0M	30	3	$33.3K
6	MACLEODS PHARMACEUTICALS LTD	$850.0K	17	3	$50.0K
11	STRIDES PHARMA SCIENCE LIMITED	$781.6K	73	2	$10.7K

Cadila Healthcare Limited ranks #9 among 277 Indian Meloxicam exporters. Average shipment value of $33.3K compared to the market average of $227.2K. The closest competitors by value are AUROBINDO PHARMA LTD and GRACURE PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Meloxicam Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	583	17.7%
JNPT/ NHAVA SHEVA SEA	374	11.3%
SAHAR AIR	370	11.2%
SAHAR AIR CARGO ACC (INBOM4)	276	8.4%
JNPT	242	7.3%
NHAVA SHEVA	147	4.5%
MUNDRA SEA	137	4.2%
Bombay Air	117	3.5%

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Meloxicam Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zydus. The escalating conflict in the Middle East has disrupted key maritime routes, particularly the Red Sea and Suez Canal, leading to longer transit times and increased freight costs. Major carriers have suspended or restricted transits, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes. (livemint.com) This situation poses significant challenges for time-sensitive pharmaceutical shipments, especially temperature-sensitive medicines. (economictimes.indiatimes.com)

Conversely, U.S.–China trade tensions have prompted the U.S. to impose tariffs on Chinese pharmaceutical imports, creating an opportunity for Indian exporters to fill the supply gap. However, the U.S. has also introduced tariffs on Indian imports, including a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) While pharmaceuticals are currently exempt, the potential for future tariffs necessitates strategic planning.

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial. The FMD mandates stringent serialization and traceability requirements to prevent counterfeit medicines from entering the supply chain. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU Good Manufacturing Practice (GMP) guidelines set stringent quality benchmarks. Any lapses can lead to import alerts, product recalls, or facility shutdowns. For instance, in 2019, Zydus's Moraiya facility received an Official Action Indicated (OAI) classification from the U.S. FDA, indicating that regulatory and/or administrative actions were recommended. (moneycontrol.com) Such events underscore the importance of robust quality assurance systems.

The evolving regulatory landscape demands continuous investment in compliance infrastructure. The EU's Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act (DSCSA) require advanced serialization and traceability measures. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Meloxicam shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cadila Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 39 individual customs records matching Cadila Healthcare Limited exporting Meloxicam, covering 28 formulations to 3 countries via 4 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 566+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Meloxicam

Meloxicam

Cadila Healthcare Limited — Meloxicam Exporter Profile

Cadila Healthcare Limited — Meloxicam Export Profile: Buyers & Destinations

Where Does Cadila Healthcare Limited Export Meloxicam?

Who Are the Top Buyers of Meloxicam from Cadila Healthcare Limited?

What Is India's Total Meloxicam Export Value and How Much Does Cadila Healthcare Limited Contribute?

What Is the Average Shipment Value for Cadila Healthcare Limited's Meloxicam Exports?

How Does Cadila Healthcare Limited Compare to Other Indian Meloxicam Exporters?

What Meloxicam Formulations Does Cadila Healthcare Limited Export?

Regulatory Requirements: Exporting Meloxicam to Key Markets

United States — FDA

South Africa — SAHPRA

How Does Cadila Healthcare Limited Compare to Nearest Meloxicam Exporters?

Which Indian Ports Ship Meloxicam Exports?

What Other Analgesics & Antipyretics Products Does Cadila Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Meloxicam Exports

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

About Cadila Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Meloxicam Export Data from Cadila Healthcare Limited

Meloxicam Stats

Company Overview

Top Products by Cadila Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source